Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Onto Innovation (ONTO) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Onto InnovationTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Onto Innovation vs Vir Biotechnology Inc. Common Stock — how do they compare? Onto Innovation trades at $236.5 (market cap $12.93B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Onto Innovation is far larger — about 7.2× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Onto Innovation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Onto Innovation for 7 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

ONTOVIR
Market Cap
$12.93B$1.80B
Volume
1,098,2591,782,836
Sector
TechnologyHealth
52-Week High
$378.45$11.78
52-Week Low
$124.09$5.12
Typical Hold Time
7 Days0 Days
Enterprise Value
$12.52B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Onto Innovation

ONTO trades at $263.55, down 3.72% with bearish technical signals but strong analyst support. The stock shows mixed earnings performance with a Q2 2026 beat but misses in prior quarters. Revenue grew to $1.01B in 2025 with 11.84% net margin, though valuation remains elevated at P/E 98.71. Recent news highlights a $1.1B backlog and strategic partnerships in semiconductor manufacturing.

Outlook remains positive with 100% analyst buy ratings and $387 consensus target suggesting 47% upside. Key risks include high valuation multiples and semiconductor cycle volatility. Growth catalysts include AI-driven demand and Dragonfly G5 product momentum, though execution on backlog conversion is critical.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ONTO
100% Buy0% Sell
Avg holding period · 7 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Onto Innovation

Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.

Read more on ONTO →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →